Hospitalisation Utilisation and Costs in Schizophrenia Patients in Finland before and after Initiation of Risperidone Long-Acting Injection

Table 2

Length of follow-up and of hospitalisation episodes.

Variable	𝑁	Mean	Standard deviation	Min	Max
Follow-up prior to initiation of RLAI (years)	177	2.00	—	—	—
Follow-up following initiation of RLAI (years)	177	1.80	0.45	0.43	2.56
Proportion of patients hospitalised at initiation of RLAI	177	127 (72%)	—	—	—
Hospital length of stay (days per episode)
All Episodes	576	65.0	95.4	0*	816
Episodes strictly before RLAI initiation	227	45.6	53.2	1	405
Episodes overlapping RLAI initiation	128	120.1	145.0	9	816
Episodes strictly after RLAI initiation	221	53.0	80.3	0*	638

*Inpatient hospitalisation episodes that recorded discharge on the day of admissions were assigned a duration of zero days.